Trial intelligence / Profile preview

Pilot Study of Antimalarial Drugs Against Plasmodium Falciparum in Healthy Volunteers

NCT01055002Phase 2Completed

Sponsor
Medicines for Malaria Venture
Start
Jan 2010
Primary completion
Jul 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial in malaria comparing Artemether/lumefantrine tablets with Atovaquone/Proguanil HCl tablets (2 arms). Primary endpoint: Parasite clearance rates by PCR. Started Jan 2010; status: completed.

02

Drugs

artemetherlumefantrineatovaquoneproguanil
03

Conditions

malaria

Beyond the preview

Go deeper on NCT01055002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01055002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call